TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional ...

New York- and Alabama-based IN8bio is leveraging gamma-delta (γδ) T cell biology to merge innate and adaptive immune capabilities against cancer. Has some of the early excitement in the cell ...

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune ...

(Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced today a poster presentation on its ...

Instead of the typical alpha beta T cells used in CAR-T therapy, Zhang and the team at Unicet Biotech focus on gamma delta T cells which recognise cancerous tissue using an entirely different ...

Securing the $5.1 million repayment waiver is a significant milestone in this effort. This waiver strengthens our balance sheet by eliminating this outstanding debt obligation. We are grateful for the ...

Market movers: Delta Air Lines, Walmart, New Era Helium ...

TC BioPharm is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gamma-delta T-cell therapies for cancer treatment with human efficacy data in ...

Our hope is that not only will this treatment work for osteosarcoma but also other adult cancers The study in mice found that using a small subset of immune cells, called gamma-delta T cells ...

White blood cells in the GI tract known as intraepithelial lymphocytes express the gamma delta T cell receptor (gamma delta IELs), which prevent infection and provide surveillance for the ...